U.S. Semiconductors Stock News

Thinking about whether Nextpower is a good buy right now? You're not alone, as questions about its value have been buzzing with the stock's impressive climb. In just the past year, Nextpower shares have surged by 140.9%, including a 129.2% gain year-to-date. However, they have dipped 6.2% over the last week. Much of the excitement comes on the heels of industry-wide optimism for clean energy and news of a high-profile partnership with a major utility. Both of these factors have contributed...

Origin Bancorp recently completed a share repurchase program, buying back 265,248 shares, or 0.85% of its outstanding shares, for US$9.51 million between July 1, 2025 and November 5, 2025. This move signals management's confidence in the company's current valuation while aligning with ongoing investments in digital banking and efficiency improvements. We'll examine how the completion of the buyback program supports Origin Bancorp's investment narrative and long-term operational...

Fair Isaac (FICO) has drawn attention with its recent earnings report, showing strong revenue and profit gains for the fourth quarter. The company’s Scores segment stands out for its impressive year-over-year growth, which reflects momentum in core business lines. See our latest analysis for Fair Isaac. Fair Isaac’s recent momentum is hard to miss. Beyond its strong quarterly results, the company completed a major buyback program and landed new partnerships in fraud prevention and financial...

WeRide has been granted approval to operate fully driverless Robotaxi services in Abu Dhabi, allowing commercial operations without an onboard safety driver and making it the first international company outside the U.S. to achieve this milestone at the city level. This regulatory success not only enables WeRide to reach financial breakeven on unit economics but also positions the company to expand its autonomous fleet and geographic coverage in the region. We'll explore how the elimination...

The Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) share price has done very well over the last month, posting an...

The latest announcement from Zymeworks (NasdaqGS:ZYME) centers on the positive topline readout from its Phase 3 HERIZON-GEA-01 trial for Ziihera. The trial delivered notable clinical benefit in HER2-positive gastroesophageal cancer patients. See our latest analysis for Zymeworks. Recent weeks have seen Zymeworks making headlines by announcing a $125 million share repurchase plan, refreshing its board, and securing a four-year high in its share price after releasing strong clinical data for...

Kemper (KMPR) just posted its third quarter results, switching to a net loss after being profitable at the same time last year. Alongside earnings, the company completed major share repurchases, moves that can shift how investors view the stock. See our latest analysis for Kemper. Despite some bold moves like completing major buybacks and affirming its dividend, Kemper’s momentum has faded as investors reacted to weaker results. The share price sits at $36.89, with a steep 30-day share price...

Intuit recently announced a multi-year partnership with OpenAI to integrate its AI-powered financial tools directly into ChatGPT, granting users seamless access to personalized financial insights and the ability to act on recommendations within the chat platform. This collaboration significantly expands Intuit's reach, enabling its AI-driven apps to meet both consumers and businesses directly at their point of need, while deepening customer relationships and broadening its total addressable...

CarMax (KMX) stock has caught investor attention this week, largely due to a strategic leadership shakeup. With Bill Nash stepping down as CEO and David McCreight stepping in as interim chief, the company is entering a new chapter. See our latest analysis for CarMax. The recent shakeup in CarMax’s executive team has come alongside bold product rollouts, but those moves have not been enough to reverse a tough run for shareholders. The company’s 1-day share price return jumped 4.1 percent on...

Philip Morris International (PM) is taking an active step in debt management by announcing plans to redeem $1.7 billion of its 4.875% notes ahead of schedule. This decision highlights deliberate capital allocation and signals financial confidence to investors. See our latest analysis for Philip Morris International. This proactive debt move comes after a rollercoaster year for Philip Morris International’s share price, with recent turbulence following mixed earnings. A solid revenue beat but...

Highwoods Properties (HIW) has seen its stock edge slightly higher recently, with shares moving up around 1% in the latest session. Investors appear to be weighing current market performance in addition to the company’s fundamentals and recent financial trends. See our latest analysis for Highwoods Properties. Over the past year, Highwoods Properties has faced a modest 4.45% total shareholder return decline, reflecting cautious sentiment even as the broader real estate sector adjusts to...

Allegro MicroSystems (ALGM) shares have drawn attention as investors look at a sharp drop over the past month. The semiconductor company’s performance, set against a challenging market backdrop, is prompting questions about how shares are currently valued. See our latest analysis for Allegro MicroSystems. This month’s slide adds to what’s already been a turbulent ride for Allegro MicroSystems. While the company is only up 1.75% on a share price basis year-to-date, its total shareholder return...

Baidu (NasdaqGS:BIDU) released its third-quarter earnings, and the numbers came in below expectations. Revenue dropped, and the company posted a net loss. Investors are paying close attention to these results given the headwinds faced in China. See our latest analysis for Baidu. Baidu’s stock has been on a rollercoaster lately, with the share price jumping over 35% in the past three months but sliding more than 11% in the last week alone. Despite strong moves in AI and autonomous driving,...

Wondering whether Pinterest stock is truly a bargain or just catching your eye? Let’s dig into what the numbers and recent market sentiment are revealing so you can decide with confidence. Pinterest's share price has seen some notable movement lately, falling 5.8% in the past week and dropping 20.4% over the last month, with a year-to-date decrease of 15.7%. These price changes have caught the attention of investors, especially after recent analyst upgrades and social media buzz around user...

BBB Foods (TBBB) is set to announce its third-quarter earnings after the market closes on November 19, 2025. This has drawn keen attention from investors focused on the company's earnings and guidance for the next quarter. See our latest analysis for BBB Foods. With anticipation building ahead of earnings, BBB Foods’ 1-month share price return of 8% and recent upward momentum suggest investors are watching for positive surprises and renewed growth signals. However, the total shareholder...

Earlier this month, Raytheon signed a Memorandum of Understanding with Avio to help establish a new solid rocket motor facility in the United States, securing preferred production capacity to meet future defense demand, while Collins Aerospace, an RTX business, was chosen by Qatar Airways to provide predictive analytics for its Boeing 787 fleet using the Ascentia™ solution. These agreements highlight RTX's expanding presence in both commercial aerospace technology and advanced defense...

Mineralys Therapeutics (MLYS) delivered third-quarter results that showed a smaller net loss than a year ago, signaling some operational progress. Alongside earnings, the company also filed a $300 million shelf registration. See our latest analysis for Mineralys Therapeutics. Mineralys Therapeutics has seen its 90-day share price return skyrocket an impressive 196.99 percent, helping drive a year-to-date share price return of 254.20 percent. Momentum has been building, with positive investor...

Dianthus Therapeutics (DNTH) just released its latest quarterly earnings, showing both revenue and net losses moving in the wrong direction compared to last year. Investors are now taking a closer look at these results. See our latest analysis for Dianthus Therapeutics. Despite posting wider losses in its latest results, Dianthus Therapeutics continues to draw investor interest. Its 1-year total shareholder return has reached 97%, and the share price is up over 75% so far this year. The...

Colgate-Palmolive (CL) has seen its stock deliver mixed returns recently, moving sideways over the past month but down about 13% over the past year. The company’s steady fundamentals have kept investors watching for signs of a turnaround. See our latest analysis for Colgate-Palmolive. Colgate-Palmolive’s share price has stayed within a narrow range despite solid revenue and income growth, reflecting a cautious outlook among investors. With a 1-year total shareholder return of -13.2% but a...

Thinking about whether MSCI's stock is a bargain right now? If you've ever wondered how to weigh up price versus value, you're in the right place. Recently, MSCI's stock price has been a bit of a rollercoaster. It rose 4.2% in the past month, slipped 4.7% over the last week, and is down 6.7% year-to-date. These moves have come after news that MSCI has been expanding its climate risk data offerings and making strategic acquisitions in risk analytics. This has fueled investor debate about...

Principal Financial Group (PFG) recently caught Wall Street’s attention with third-quarter earnings that topped forecasts, along with an encouraging outlook from management. This combination underscores Principal’s current financial strength and supports the case for continued stability. See our latest analysis for Principal Financial Group. Following upbeat earnings and a confident outlook from management, Principal Financial Group’s share price momentum appears to be building, with a 4.5%...

Madrigal Pharmaceuticals recently reported positive two-year data from the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra in patients with compensated MASH cirrhosis, highlighting statistically significant improvements in imaging and biomarker parameters for a population without approved therapies. This progress was presented at The Liver Meeting® and accompanied by strong third-quarter earnings with Rezdiffra’s net revenues and patient usage outperforming market expectations. We’ll explore how...

Curious whether Marathon Petroleum is a bargain at today's price, or just riding recent market momentum? Let's break down what really matters for long-term investors looking for value. After a year-to-date gain of 41.1% and a five-year return that tops 430%, Marathon Petroleum has certainly rewarded shareholders, even with a recent week in the red at -0.3%. This price action comes as traders react to developments like evolving energy market supply dynamics and persistent chatter over U.S...

On November 6, 2025, Sunrun Inc. reported strong third-quarter results, highlighted by substantial revenue growth to US$724.56 million and a return to profitability, and announced the appointment of Craig Cornelius as a new director, expanding the board to nine members. Mr. Cornelius brings over a decade of renewable energy leadership experience to Sunrun's board, including key executive roles in solar and storage at Clearway Energy and NRG, which may bolster the company's strategic...